PEOPLE
WHAT WE DO
HOW WE SEE IT
CONTACT
HOME
Pluristem Therapeutics, Inc
in
Cardiovascular Disease
Corporate Finance
Pluristem Therapeutics, Inc.
has announced a Units, Common Stock, Warrants offering in the amount of $1.04 million.
Login
to post comments
